<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="741f71b5-5a7a-43dc-9937-066d99c50707"><labelDrug name="Phoslyra"><Normalization><mmtx cui="C3153639" preferredWord="Phoslyra" semType="inch, phsu"/></Normalization></labelDrug><generic name="calcium acetate oral solution"/><sentence id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.1" text="Drug Label for drug brand Phoslyra, containing calcium acetate oral solution." type="negative"><entity charOffset="0:19" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.1.e.0" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Phoslyra," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="26:34" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.1.e.1" text="phoslyra" type="Biomedical_Entity"><Normalization><mmtx cui="C3153639" phraseText="Drug Label for drug brand Phoslyra," preferredWord="Phoslyra" semType="inch, phsu"/><RxNorm RxCui="1099805"/></Normalization></entity><entity charOffset="47:76" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.1.e.2" text="calcium acetate oral solution" type="Biomedical_Entity"><Normalization><mmtx cui="C3153637" phraseText="calcium acetate oral solution." preferredWord="calcium acetate Oral Solution" semType="clnd"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.1.e.0" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.1.e.1"/><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.1.e.0" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.1.e.2"/><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.1.e.1" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.1.e.2"/></sentence><sentence id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.7" text="&lt;item&gt;Treat mild hypercalcemia by reducing or interrupting PHOSLYRA and Vitamin D. " type="negative"><entity charOffset="72:81" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.7.e.0" text="vitamin d" type="Biomedical_Entity"><Normalization><mmtx cui="C3537249" phraseText="Vitamin D." preferredWord="D Vitamin" semType="phsu"/><RxNorm RxCui="604318"/></Normalization></entity><entity charOffset="59:67" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.7.e.1" text="phoslyra" type="Biomedical_Entity"><Normalization><mmtx cui="C3153639" phraseText="interrupting PHOSLYRA" preferredWord="Phoslyra" semType="inch, phsu"/><RxNorm RxCui="1099805"/></Normalization></entity><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.7.e.1" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.7.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.10" lineNumber="22" text="&lt;item&gt;May cause diarrhea with nutritional supplements that contain maltitol. " type="irregular"><entity charOffset="16:24" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.10.e.1" text="diarrhea" type="Specific_Interaction"><Normalization><mmtx cui="C0011991" phraseText="diarrhea with nutritional supplements" preferredWord="Diarrhea" semType="sosy"/></Normalization></entity><entity charOffset="30:75" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.10.e.2" text="nutritional supplements that contain maltitol" type="Substance"><Normalization><mmtx cui="C0065600" phraseText="maltitol." preferredWord="maltitol" semType="phsu, carb"/><RxNorm RxCui="1021991"/></Normalization></entity><drugInteraction id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.10.ddi.1"><interaction trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.10.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.8" text="Severe hypercalcemia may require hemodialyis and discontinuation of PHOSLYRA. "><entity charOffset="68:76" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.8.e.0" text="PHOSLYRA" type="Drug"><Normalization><mmtx cui="C3153639" phraseText="discontinuation of PHOSLYRA." preferredWord="Phoslyra" semType="inch, phsu"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.9" text="(5.1)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.10.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.10.e.2"/></sentence><sentence id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.13" text="Patients with end stage renal disease may develop hypercalcemia when treated with calcium, including calcium acetate (PHOSLYRA). " type="negative"><entity charOffset="101:116" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.13.e.0" text="calcium acetate" type="Biomedical_Entity"><Normalization><mmtx cui="C0717537" phraseText="calcium acetate" preferredWord="calcium acetate" semType="phsu, irda, orch"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="82:89" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.13.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C0006675" phraseText="treated with calcium," preferredWord="Calcium" semType="bacs, phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="118:126" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.13.e.2" text="phoslyra" type="Biomedical_Entity"><Normalization><mmtx cui="C3153639" phraseText="(PHOSLYRA" preferredWord="Phoslyra" semType="inch, phsu"/><RxNorm RxCui="1099805"/></Normalization></entity><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.13.e.1" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.13.e.0"/><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.13.e.0" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.13.e.2"/><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.13.e.1" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.13.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14" lineNumber="29" text="Avoid the concurrent use of calcium supplements, including calcium-based nonprescription antacids, with PHOSLYRA." type="regular"><entity charOffset="0:5" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="104:112" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.2" text="PHOSLYRA" type="Drug"><Normalization><mmtx cui="C3153639" phraseText="with PHOSLYRA." preferredWord="Phoslyra" semType="inch, phsu"/><RxNorm RxCui="1099805"/></Normalization></entity><entity charOffset="28:47" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.3" text="calcium supplements" type="Drug_Class"><Normalization><mmtx cui="C3540037" phraseText="the concurrent use of calcium supplements," preferredWord="CALCIUM SUPPLEMENTS" semType="phsu, vita"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="59:97" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.4" text="calcium-based nonprescription antacids" type="Drug_Class"><Normalization><mmtx cui="C0304542" phraseText="calcium-based nonprescription antacids," preferredWord="Calcium antacid" semType="inch, phsu"/><mmtx cui="C0013231" phraseText="calcium-based nonprescription antacids," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="91254"/></Normalization></entity><drugInteraction id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.ddi.1"><interaction trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.3" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.2" trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.4" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.2" trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.1" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.3" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.14.e.4"/></sentence><sentence id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.27" text="Maintain the serum calcium-phosphorus (Ca x P) product below 55 mg2/dL2." type="negative"><entity charOffset="19:26" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.27.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="the serum calcium-phosphorus (Ca x P) product below 55 mg2/dL2." preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="64:67" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.27.e.1" text="mg2" type="Biomedical_Entity"><Normalization><mmtx cui="C2346927" phraseText="the serum calcium-phosphorus (Ca x P) product below 55 mg2/dL2." preferredWord="Magnesium Cation" semType="phsu, elii"/><RxNorm RxCui="315"/></Normalization></entity><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.27.e.0" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.27.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.30" lineNumber="40" text="PHOSLYRA contains maltitol (1 g per 5 mL) and may induce a laxative effect, especially if taken with other products containing maltitol." type="regular"><entity charOffset="59:74" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.30.e.1" text="laxative effect" type="Specific_Interaction"/><entity charOffset="107:135" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.30.e.2" text="products containing maltitol" type="Substance"><Normalization><mmtx cui="C0065600" phraseText="maltitol." preferredWord="maltitol" semType="phsu, carb"/><RxNorm RxCui="114200"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.30.e.3" text="PHOSLYRA" type="Drug"><Normalization><mmtx cui="C3153639" phraseText="PHOSLYRA" preferredWord="Phoslyra" semType="inch, phsu"/><RxNorm RxCui="1099805"/></Normalization></entity><drugInteraction id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.30.ddi.1"><interaction trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.30.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.30.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.30.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.30.e.3" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.30.e.2" trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.30.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.32" text="The drug interaction profile of PHOSLYRA is characterized by the potential of calcium to bind to drugs with anionic functions (e.g., carboxyl, carbonyl, and hydroxyl groups). " type="negative"><entity charOffset="32:40" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.32.e.0" text="phoslyra" type="Biomedical_Entity"><Normalization><mmtx cui="C3153639" phraseText="The drug interaction profile of PHOSLYRA" preferredWord="Phoslyra" semType="inch, phsu"/><RxNorm RxCui="1099805"/></Normalization></entity><entity charOffset="78:85" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.32.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C0006675" phraseText="characterized by the potential of calcium to" preferredWord="Calcium" semType="bacs, phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.32.e.0" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.32.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33" lineNumber="45" text="PHOSLYRA may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism." type="regular"><entity charOffset="13:41" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.1" text="decrease the bioavailability" type="Decrease_Interaction"/><entity charOffset="0:8" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.2" text="PHOSLYRA" type="Drug"><Normalization><mmtx cui="C3153639" phraseText="PHOSLYRA" preferredWord="Phoslyra" semType="inch, phsu"/><RxNorm RxCui="1099805"/></Normalization></entity><entity charOffset="62:78" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.3" text="fluoroquinolones" type="Drug_Class"><Normalization><mmtx cui="C0949665" phraseText="fluoroquinolones via this mechanism." preferredWord="Fluoroquinolones" semType="phsu, orch"/><RxNorm RxCui="1427693"/></Normalization></entity><entity charOffset="45:58" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.4" text="tetracyclines" type="Drug_Class"><Normalization><mmtx cui="C1744619" phraseText="the bioavailability of tetracyclines" preferredWord="Tetracycline Antibiotics" semType="orch, antb"/><RxNorm RxCui="142446"/></Normalization></entity><drugInteraction id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.ddi.1"><interaction trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.2" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.3" trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.2" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.4" trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.33.e.1" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.34" text="There are no empirical data on avoiding drug interactions between calcium acetate or PHOSLYRA and most concomitant drugs. " type="negative"><entity charOffset="10:27" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.34.e.0" text="no data" type="Biomedical_Entity"><Normalization><mmtx cui="C1572381" phraseText="no empirical data on avoiding drug interactions" preferredWord="No Data re: Ingredient" semType="phsu"/><RxNorm RxCui="53704"/></Normalization></entity><entity charOffset="85:93" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.34.e.1" text="phoslyra" type="Biomedical_Entity"><Normalization><mmtx cui="C3153639" phraseText="PHOSLYRA" preferredWord="Phoslyra" semType="inch, phsu"/><RxNorm RxCui="1099805"/></Normalization></entity><entity charOffset="66:81" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.34.e.2" text="calcium acetate" type="Biomedical_Entity"><Normalization><mmtx cui="C0717537" phraseText="between calcium acetate" preferredWord="calcium acetate" semType="phsu, irda, orch"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.34.e.0" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.34.e.1"/><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.34.e.0" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.34.e.2"/><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.34.e.2" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.34.e.1"/></sentence><sentence id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.35" text="When administering and oral medication with PHOSLYRA where a reduction in the bioavailability of that medication would have a clinically significant effect on its safety or efficacy, administer the drug one hour before or three hours after PHOSLYRA or calcium acetate. " type="negative"><entity charOffset="252:267" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.35.e.0" text="calcium acetate" type="Biomedical_Entity"><Normalization><mmtx cui="C0717537" phraseText="calcium acetate." preferredWord="calcium acetate" semType="phsu, irda, orch"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="44:52" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.35.e.1" text="phoslyra" type="Biomedical_Entity"><Normalization><mmtx cui="C3153639" phraseText="oral medication with PHOSLYRA where" preferredWord="Phoslyra" semType="inch, phsu"/><RxNorm RxCui="1099805"/></Normalization></entity><entity charOffset="240:248" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.35.e.2" text="phoslyra" type="Biomedical_Entity"><Normalization><mmtx cui="C3153639" phraseText="three hours after PHOSLYRA" preferredWord="Phoslyra" semType="inch, phsu"/><RxNorm RxCui="1099805"/></Normalization></entity><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.35.e.1" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.35.e.0"/><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.35.e.2" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.35.e.0"/></sentence><sentence id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.37" text="Patients taking anti-arrhythmic medications for the control of arrhythmias and anti-seizure medications for the control of seizure disorders were excluded from the clinical trials with all forms of calcium acetate." type="negative"><entity charOffset="198:213" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.37.e.0" text="calcium acetate" type="Biomedical_Entity"><Normalization><mmtx cui="C0717537" phraseText="forms of calcium acetate." preferredWord="calcium acetate" semType="phsu, irda, orch"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="84:103" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.37.e.1" text="seizure medications" type="Biomedical_Entity"><Normalization><mmtx cui="C0748603" phraseText="anti-seizure medications for the control of seizure disorders" preferredWord="seizure medication" semType="phsu"/><RxNorm RxCui="1023130"/></Normalization></entity><entity charOffset="16:31" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.37.e.2" text="anti-arrhythmic" type="Biomedical_Entity"><Normalization><mmtx cui="C3537142" phraseText="anti-arrhythmic medications for the control of arrhythmias" preferredWord="Antiarrhythmic [EPC]" semType="phsu"/><RxNorm RxCui="1436910"/></Normalization></entity><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.37.e.1" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.37.e.0"/><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.37.e.2" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.37.e.0"/><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.37.e.2" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.37.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38" lineNumber="49" text="&lt;item&gt;PHOSLYRA may decrease the bioavailability of tetracyclines or fluoroquinolones. " type="regular"><entity charOffset="19:47" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.1" text="decrease the bioavailability" type="Decrease_Interaction"/><entity charOffset="6:14" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.2" text="PHOSLYRA" type="Drug"><Normalization><mmtx cui="C3153639" phraseText="&gt;PHOSLYRA" preferredWord="Phoslyra" semType="inch, phsu"/><RxNorm RxCui="1099805"/></Normalization></entity><entity charOffset="51:64" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.3" text="tetracyclines" type="Drug_Class"><Normalization><mmtx cui="C1744619" phraseText="the bioavailability of tetracyclines" preferredWord="Tetracycline Antibiotics" semType="orch, antb"/><RxNorm RxCui="142446"/></Normalization></entity><entity charOffset="68:84" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.4" text="fluoroquinolones" type="Drug_Class"><Normalization><mmtx cui="C0949665" phraseText="fluoroquinolones." preferredWord="Fluoroquinolones" semType="phsu, orch"/><RxNorm RxCui="1427693"/></Normalization></entity><drugInteraction id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.ddi.1"><interaction trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.2" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.3" trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.2" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.4" trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.38.e.1" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.40" text="&lt;item&gt;When clinically significant drug interactions are expected, administer the drug at least one hour before or at least three hours after PHOSLYRA, or consider monitoring blood levels of the drug. " type="negative"><entity charOffset="174:198" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.40.e.0" text="blood drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0018938" phraseText="monitoring blood levels of the drug." preferredWord="Hematologic Agents" semType="phsu"/><RxNorm RxCui="1629"/></Normalization></entity><entity charOffset="141:149" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.40.e.1" text="phoslyra" type="Biomedical_Entity"><Normalization><mmtx cui="C3153639" phraseText="after PHOSLYRA," preferredWord="Phoslyra" semType="inch, phsu"/><RxNorm RxCui="1099805"/></Normalization></entity><pair ddi="false" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.40.e.1" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.40.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43" lineNumber="58" text="In a study of 15 healthy subjects, a co-administered single dose of 4 calcium acetate tablets (approximately 2.7 g) decreased the bioavailability of ciprofloxacin by approximately 50%." type="regular"><entity charOffset="116:145" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.e.1" text="decreased the bioavailability" type="Decrease_Interaction"/><entity charOffset="14:33" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.e.2" text="15 healthy subjects" type="SPAN"/><entity charOffset="70:93" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.e.3" text="calcium acetate tablets" type="Drug"><Normalization><mmtx cui="C0717537" phraseText="single dose of 4 calcium acetate tablets" preferredWord="calcium acetate" semType="phsu, irda, orch"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="149:162" id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.e.4" text="ciprofloxacin" type="Drug"><Normalization><mmtx cui="C0008809" phraseText="the bioavailability of ciprofloxacin" preferredWord="Ciprofloxacin" semType="phsu, orch"/><RxNorm RxCui="81981"/></Normalization></entity><drugInteraction id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.ddi.1"><interaction trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.e.1"><relations><relation type="hasEvidence"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.e.3" e2="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.e.4" evidence="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.e.2" trigger="Dailymed.741f71b5-5a7a-43dc-9937-066d99c50707.s.43.e.1" type="Decrease_Interaction"/></sentence><positiveExamples number="9"/><negativeExamples number="19"/></document>